Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Reviews in the Neurosciences
|
January 17, 2009
Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process
Gregory L Willis
Chronobiology International
|
November 28, 2022
Stuart Maxwell Armstrong (1947-2022)
Gregory L Willis
Brain Sciences
|
October 29, 2025
The Effect of Intraocular Haloperidol on Motor Function in Models of Two Neuropsychiatric Disorders: Implications for the Origin and Treatment of Parkinson's Disease, Psychosis and Drug Addiction
Gregory L Willis
Drug News & Perspectives
|
December 20, 2005
The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease
Gregory L Willis
Behavioural Brain Research
|
April 20, 2005
The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function
Gregory L Willis
Brain Research
|
May 27, 2008
Intraocular microinjections repair experimental Parkinson's disease
Gregory L Willis
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 31, 2016
Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?
Aleksandar Videnovic, Gregory L Willis
Pharmacology, Biochemistry, and Behavior
|
January 18, 2005
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23
Gregory L Willis, Alan D Robertson
Frontiers in Neurology
|
July 21, 2017
Neurochemical Systems of the Retina Involved in the Control of Movement
Gregory L Willis, Christopher B Freelance
Brain Research
|
September 30, 2017
Emerging preclinical interest concerning the role of circadian function in Parkinson's disease
Gregory L Willis, Christopher B Freelance
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Reviews in the Neurosciences
|
January 17, 2009
Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process
Gregory L Willis
Chronobiology International
|
November 28, 2022
Stuart Maxwell Armstrong (1947-2022)
Gregory L Willis
Brain Sciences
|
October 29, 2025
The Effect of Intraocular Haloperidol on Motor Function in Models of Two Neuropsychiatric Disorders: Implications for the Origin and Treatment of Parkinson's Disease, Psychosis and Drug Addiction
Gregory L Willis
Drug News & Perspectives
|
December 20, 2005
The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease
Gregory L Willis
Behavioural Brain Research
|
April 20, 2005
The therapeutic effects of dopamine replacement therapy and its psychiatric side effects are mediated by pineal function
Gregory L Willis
Brain Research
|
May 27, 2008
Intraocular microinjections repair experimental Parkinson's disease
Gregory L Willis
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 31, 2016
Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?
Aleksandar Videnovic, Gregory L Willis
Pharmacology, Biochemistry, and Behavior
|
January 18, 2005
Recovery from experimental Parkinson's disease in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride treated marmoset with the melatonin analogue ML-23
Gregory L Willis, Alan D Robertson
Frontiers in Neurology
|
July 21, 2017
Neurochemical Systems of the Retina Involved in the Control of Movement
Gregory L Willis, Christopher B Freelance
Brain Research
|
September 30, 2017
Emerging preclinical interest concerning the role of circadian function in Parkinson's disease
Gregory L Willis, Christopher B Freelance
Page
of 3